Drug Development

Share SHARE

hypodermicneedle-052812_10Jul12.jpg A new vaccine for meningitis has been greenlighted by the U.S. Food and Drug Administration. The vaccine, Trumenba, is approved for protection in people 10-25 years of age against meningococcal disease caused by Neisseria meningitidis serogroup B bacteria, of which there were outbreaks last year at Princeton University and the University of California Santa Barbara.

Painrelief-102414.jpg Contract Packaging Resources is recalling nearly 12,000 boxes of the Assured brand naproxen pain relief tablets shipped to Dollar Tree outlets. The recall was issued for 15 count bottles of 220 mg tablets of naproxen sodium, which may actually contain bottles of ibuprofen softgels in 200 mg strength. The ibuprofen tablets represent a threat to those with allergies to the drug.

vancomycin-102014.jpg Vancomycin, an older antibiotic, is still effective in treating Staphylococcus aureus (staph disease) blood infections, according to research conducted at the University of Nebraska. The study, published in the Journal of the American Medical Association, surveyed data on nearly 8,300 cases of staph.

badmedicine-093014.jpg The FDA has warned doctors that there has been an increase in the number of wholesale distributors selling fake drugs on the rise. "While the U.S. health care supply chain is one of the most secure and sophisticated in the world, there is a growing network of rogue wholesale drug distributors selling potentially unsafe drugs in the U.S. market," says the FDA.

FDA-091614.jpg The FDA has issued its approval on a new constipation drug from Nektrar Pharma and AstraZeneca. The new drug, called Movantik (naloxegol), is aimed at reducing the constipation associated with opioid pain killers without reducing the central pain killing effects. It is the first drug in its class approved by the FDA and is likely to hit the market two to three years before any competing drugs.